Haram Kjell, Søfteland Eirik, Bukowski Radek
Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway.
Obstet Gynecol Int. 2013;2013:708126. doi: 10.1155/2013/708126. Epub 2013 Jun 23.
The growth of the fetus, which is strongly associated with the outcome of pregnancy, reflects interplay of several physiological and pathological factors. The assessment of fetal growth is based on comparison of birthweight (BW) or estimated fetal weight (EFW) to standards which define reference ranges at a spectrum of gestational ages. Most birthweight standards do not take into account effects of physiological determinants of fetal growth. Additionally, gestational age in many standards is based on the menstrual history and is often inaccurate. Fetal growth norms should be based on an early ultrasound estimate of gestational age. Customized standards, which have included only ultrasound-dated pregnancies, seem to be superior to population-based birthweight norms in predicting perinatal mortality and morbidity. Adjustment for individual variation in customized growth curves reduces false-positive diagnosis of IUGR and may lead to a very significant reduction in intervention for suspected IUGR. Customized growth potential identifies better the risk for adverse outcome than the currently used national standards, but customized charts may fail in detecting growth-restricted stillbirth. An individual's birthweight is the sum of physiological and pathological influences operating during pregnancy. Growth potential norms are a better discriminator of aberrations of fetal growth than population, ultrasound, and customized norms.
胎儿的生长与妊娠结局密切相关,反映了多种生理和病理因素的相互作用。胎儿生长评估基于出生体重(BW)或估计胎儿体重(EFW)与一系列孕周参考范围标准的比较。大多数出生体重标准未考虑胎儿生长生理决定因素的影响。此外,许多标准中的孕周基于月经史,往往不准确。胎儿生长标准应基于早期超声估计的孕周。仅纳入超声确定孕周的妊娠的定制标准,在预测围产期死亡率和发病率方面似乎优于基于人群的出生体重标准。根据个体差异调整定制生长曲线可减少小于胎龄儿(IUGR)的假阳性诊断,并可能显著减少对疑似IUGR的干预。与目前使用的国家标准相比,定制生长潜能能更好地识别不良结局风险,但定制图表可能无法检测到生长受限的死产。个体的出生体重是孕期生理和病理影响的总和。生长潜能标准比人群、超声和定制标准更能区分胎儿生长异常。